References
- Donnelly CA, Seth J, Clayton RM, Phillips CI, Cuthbert J, Prescott RJ. Some blood plasma constituents correlate with human cataract. Br J Ophthalmol 1995;79:1036–41.
- Tavani A, Negri E, La Vecchia C. Selected diseases and risk of cataract in women. A case-control study from northern Italy. Ann Epidemiol 1995;5: 234–8.
- Caird Fl, Hutchinson M, Pine A.Cataract and diabetes. Br Med J 1964; 2:665–8.
- Kahn HA, Leibowitz HM, Ganley JP, et al. The Framingham Eye Study. II. Association of ophthalmic pathology with single variables previously measured in the Framingham Heart Study. Am J Epidemiol 1977;106:33–41.
- Klein BEK, Klein R, Wang Q, Moss SE. Older-onset diabetes and lens opacities. The Beaver Dam Eye Study. Ophthalm Epidemiol 1995;2:49–55.
- Hiller R, Sperduto RD, Ederer F.Epidemiologic associations with cataract in the 1971–1972 National Health and Nutrition Examination Survey. Am J Epidemiol 1983;118: 239–49.
- Ederer F, Hiller R, Taylor HR. Senilelens changes and diabetes in two population studies. Am J Ophthalmol 1981;91:381–95.
- Schwab IR, Dawson CR, Hoshiwara I, Szuter CF, Knowler WC. Incidence of cataract extraction in Pima Indians. Diabetes as a risk factor. Arch Ophthalmol 1985;103:208–12.
- McGuinness R. Association of diabetes and cataract. Br Med J 1967; 2:416–8.
- The Italian-American Cataract Study Group. Risk factors for age-related cortical, nuclear, and posterior subcapsular cataracts. Am J Epidemiol 1991;133:541–53.
- Mitchell P, Cumming RG, Attebo K, Panchapakesan J. Prevalence of cataract in Australia: the Blue Mountains Eye Study. Ophthalmology 1997;104:581–8.
- Cumming RG, Mitchell P, Leeder SR. Use of inhaled corticosteroids and the risk of cataracts. N Engl J Med 1997; 337:8–14.
- Cumming RG, Mitchell P. Alcohol, smoking, and cataracts: the Blue Mountains Eye Study. Arch Ophthalmol 1997;115:1296–303.
- Glynn RJ, Christen WG, Manson JE, Bernheimer J, Hennekens CH. Body mass index. An independent predictor of cataract. Arch Ophthalmol 1995; 113:1131–7.
- Clayton RM, Cuthbert J, Duffy J, et al. Some risk factors associated with cataract in S.E. Scotland: a pilot study. Trans Ophthalmol Soc UK 1982;102 Pt 3:331–6.
- Stolk RP, Vingerling JR, De Jong PT, et al. Retinopathy, glucose, and insulin in an elderly population. The Rotterdam Study. Diabetes 1995;44: H–5.
- Attebo K, Mitchell P, Smith W. Visual acuity and the causes of visual loss in Australia. The Blue Mountains Eye Study. Ophthalmology 1996;103:357–64.
- Klein BEK, Klein R, Linton KL, Magli YL, Neider MW. Assessment of cataracts from photographs in the Beaver Dam Eye Study. Ophthalmolo-gy 1990;97:1428–33.
- Panchapakesan J, Cumming RG, Mitchell P. Reproducibility of the Wisconsin Cataract Grading System in the Blue Mountains Eye Study. Ophthalm Epidemiol 1997;4:119–26.
- The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1998;21:55–519.
- Armstrong BG, Sloan M. Ordinal regression models for epidemiologic data. Am J Epidemiol 1989;129:191–204.
- Hiller R, Sperduto RD, Ederer F. Epidemiologic associations with nuclear, cortical, and posterior subcapsular cataracts. Am J Epidemiol 1986;124:916–25.
- Kreines K, Rowe KW Jr. Cataracts and adult diabetes. Ohio State Med J 1979;75:782,785–6.
- Prchal J, Skalka H, Clements RS, Bradley EL, Conrad ME, Pittman C. Diabetes and risk of cataract development. Metab Pediatr Ophthalmol 1980;4:185–9.
- Miglior S, Marighi PE, Musicco M, Balestreri C, Nicolosi A, Orzalesi N. Risk factors for cortical, nuclear, posterior subcapsular and mixed cataract: a case-control study. Ophthalm Epidemiol 1994;1:93–105.
- Burditt AF, Caird FT. Natural history of lens opacities in diabetics. Br J Ophthalmol 1968;52;433-4o.
- Klein BEK, Klein R, Moss SE. Incidence of cataract surgery in the Wisconsin Epidemiologic Study of Diabetic Retinopathy. Am J Ophthalmol 1995;119:295-30o.
- Klein BEK, Klein R, Moss SE. Prevalence of cataracts in a population-based study of persons with diabetes mellitus. Ophthalmology 1985;92:1191–6.
- Lee JH, Shin DH, Lupovitch A, Shi DX. Glycosylation of lens proteins in senile cataract and diabetes mellitus. Biochem Biophys Res Commun 1984; 123:888–93.
- Altomare E, Grattagliano I, Vendemaile G, Micelli Ferrari T, Signorile A, Cardia L. Oxidative protein damage in human diabetic eye: evidence of a retinal participation. Eur J Clin Invest 1997;27:141–7.
- Kilic F, Mitton K, Dzialoszynski T, Sanford SE, Trevithick JR. Modelling cortical cataractogenesis. 14: Reduction in lens damage in diabetic rats by a dietary regimen combining vitamins C and E and beta-carotene. Dev Ophthalmol 1994;26: 63–71.
- Rogers KM, Augusteyn RC. Glutathione reductase in normal and cataractous human lenses. Exp Eye Res 1978;27:719–21.
- Costagliola C, Iuliano G, Menzione M, Nesti A, Simonelli F, Rinaldi E. Systemic human diseases as oxidative risk factors in cataractogenesis. I. Diabetes. Ophthalm Res 1988;20:308-i 6.
- Simonelli F, Nesti A, Pensa M, et al. Lipid peroxidation and human cataractogenesis in diabetes and severe myopia. Exp Eye Res 1989;49:181–7.
- Diabetes Control and Complications Trial Research Group. Progression of retinopathy with intensive versus conventional treatment in the Diabetes Control and Complications Trial. Ophthalmology 1995;102:647–61.
- Diabetes Control and Complications Trial Research Group. Effect of intensive diabetes management on macrovascular events and risk factors in the Diabetes Control and Complications Trial. Am J Cardiol 1995;75;894–903.
- Lerner BC, Varma SD, Richards RD. Polyol pathway metabolites in human cataracts. Correlation of circulating glycosylated hemoglobin content and fasting blood glucose levels. Arch Ophthalmol 1984;102:917–20.
- Koenig RJ, Peterson CM, Jones RL, Saudek C, Lehrman M, Cerami A. Correlation of glucose regulation and hemoglobin AIc in diabetes mellitus. N Engl J Med 1976;295:417–20.
- Gonen B, Rubenstein A, Rochman H, Tanega SP, Horwitz DL. Haemoglobin AI: An indicator of the metabolic control of diabetic patients. Lancet 1977;2;734–7.
- Peduzzi M, Debbia A, Monzani A, et al. Prevalence of cataracts in a population-based study of patients with diabetes mellitus. Dev Ophthalmol 1989;17:75–8.
- Karasik A, Modan M, Halkin H, Treister G, Fuchs Z, Lusky A. Senile cataract and glucose intolerance: the Israel Study of Glucose Intolerance Obesity and Hypertension (The Israel GOH Study). Diabetes Care 1984;7: 52–6.
- Al Samarrai AR, Noor Sunba MS, Ul Hassan M. The incidence of unknown diabetes mellitus and impaired glucose tolerance in idiopathic presenile cataract. Dev Ophthalmol 1989;17;79–81.
- Leske MC, Chylack LT Jr, Wu SY. The Lens Opacities Case-Control Study. Risk factors for cataract. Arch Ophthalmol 1991;109:244-51. Harding JJ, Van Heyningen R. Case-control study of cataract in Oxford. Dev Ophthalmol 1987;15: 99–103.
- Harding JJ, Harding RS, Egerton M. Risk factors for cataract in Oxfordshire: diabetes, peripheral neuropathy, myopia, glaucoma and diarrhoea. Acta Ophthalmol (Copenh) 1989;67:510–7.
- Szmyd L Jr, Schwartz B. Association of systemic hypertension and diabetes mellitus with cataract extraction. A case-control study. Ophthalmology 1989;96:1248–52.
- Adamsons I, Munoz B, Enger C, Taylor HR. Prevalence of lens opacities in surgical and general populations. Arch Ophthalmol 1991; 109:993–7.
- Bochow TW, West SK, Azar A, Munoz B, Sommer A, Taylor HR. Ultraviolet light exposure and risk of posterior subcapsular cataracts. Arch Ophthalmol 1989;107:369–72.